(Q33348698)

26 July 2017

title

Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients (English)

1 reference

26 July 2017

1 reference

Stefano Cascinu

8

0 references

author name string

Vittorio Franciosi

1

1 reference

26 July 2017

Roberto Barbieri

2

1 reference

26 July 2017

Enrico Aitini

3

1 reference

26 July 2017

Giovanna Vasini

4

1 reference

26 July 2017

Gian Carlo Cacciani

5

1 reference

26 July 2017

Roberto Capra

6

1 reference

26 July 2017

Roberta Camisa

7

1 reference

26 July 2017

publication date

1 July 2003

1 reference

26 July 2017

1 reference

26 July 2017

volume

41

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

101-106

1 reference

Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

The role of new agents in advanced non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

Managing poor performance non-small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

Oxaliplatin: a review of preclinical and clinical studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

Supraadditive effect of 2',2'-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra Thoraciques

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

New chemotherapeutic agents for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900150-8

7 January 2021

10.1016/S0169-5002(03)00150-8

Identifiers

DOI

1 reference

26 July 2017

1 reference